PSP runs exclusively on the abioSCOPE^®, an award-winning rapid diagnostics platform that leverages nanofluidics to deliver lab-quality results from a drop of blood within minutes. Seamlessly integrated into routine clinical workflows, the test delivers fast, accurate, and user-friendly results in critical care settings.  By measuring PSP levels, which are directly linked to a patient’s risk of sepsis, the test enables healthcare professionals to activate sepsis bundles earlier and improve outcomes.